Compritol®888 ATO a Lipid Excipient for Sustained Release of Highly Water Soluble Active: Formulation, Scale-up and IVIVC Study

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|10|5|548-556

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.10, Iss.5, 2013-10, pp. : 548-556

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets

By Roberts Matthew   Vellucci Daniele   Mostafa Shabbir   Miolane Cedric   Marchaud Delphine  

Drug Development and Industrial Pharmacy, Vol. 38, Iss. 9, 2012-09 ,pp. : 1068-1076

Informa Healthcare

Access to resources Recommend Favorite

Compritol(R) 888 ATO: an innovative hot-melt coating agent for prolonged-release drug formulations

By Barthelemy P.   Laforet J.P.   Farah N.   Joachim J.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 47, Iss. 1, 1999-01 ,pp. : 87-90

Elsevier

Access to resources Recommend Favorite

Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies

By Shah Mayank   Chuttani Krishna   Mishra A.K.   Pathak Kamla  

Drug Development and Industrial Pharmacy, Vol. 37, Iss. 5, 2011-05 ,pp. : 526-537

Informa Healthcare

Access to resources Recommend Favorite

Formulation and Evaluation of Novel Solid Lipid Microparticles for the Sustained Release of Ofloxacin

By  

Pharmaceutical Nanotechnology, Vol. 5, Iss. 4, 2018-01 ,pp. : 329-341

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of dibutyrylchitin as new excipient for sustained drug release

By Casettari Luca   Cespi Marco   Castagnino Enzo  

Drug Development and Industrial Pharmacy, Vol. 38, Iss. 8, 2012-08 ,pp. : 979-984

Informa Healthcare

Access to resources Recommend Favorite